Effects of camel thorn distillate on recurrent oral aphthous lesions;Wirkung von Kameldornbuschdestillat auf Chronisch-rezidivierende Aphthen

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 5, 2010, Pages 348-352

  Pourahmad, Morteza ^a   Rahiminejad, Masood ^a   Fadaei, Sara ^a   Kashafi, Hamed ^a  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alhagi camelorum; Aphthous lesion; Flavanone; Oral ulcer

Indexed keywords

ALHAGIDIN; ALHAGITIN; CAMEL THORN DISTILLATE; DICLOFENAC; DOXYCYCLINE; FLAVANONE DERIVATIVE; HERBACEOUS AGENT; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GLYCOSIDE; PLANT EXTRACT;

APHTHOUS ULCER; ARTICLE; CAMEL THORN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; LEGUME; LYMPHOCYTE; MEDICINAL PLANT; MONONUCLEAR CELL; MOUTH LESION; PAIN; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; CHRONIC DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; IRAN; MALE; MIDDLE AGED; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STOMATITIS, APHTHOUS; TREATMENT OUTCOME;

ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FLAVANONES; GLYCOSIDES; HUMANS; IRAN; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; SECONDARY PREVENTION; STOMATITIS, APHTHOUS; TREATMENT OUTCOME;

EID: 77951836469     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2010.07316.x     Document Type: Article

References (23)

1. Jiang XW, Hu J, Mian FI. A new therapeutic candidate for oral aphthous ulcer: Allicin. Med Hypotheses 2008 71 (6 897 899.
2. Kutcher MJ, Ludlow JB, Samuelson AD, Campbell T, Pusek SN. Evaluation of a bioadhesive device for the management of aphthous ulcers. J Am Dent Assoc 2001 132 (3 368 376.
3. Fridh G, Koch G. Effect of a mouth rinse containing amyloglucosidase and glucose oxidase on recurrent aphthous ulcers in children and adolescents. Swed Dent J 1999 23 (2-3 49 57.
4. Sharquie K, Al-Tammimy S, Al-Mashhadani S, Hayani R, Al-Nuaimy A. Lactic acid 5 percent mouthwash is an effective mode of therapy in treatment of recurrent aphthous ulcerations. Dermatology online journal 2006 12 (7 2.
5. Greeberg M, Glick M, editors. Burker's Oral Medicine, Diagnosis and Treatment. 10th ed., BC Decker
6. Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka S, Kogure M, Mizushima Y. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: a randomised, double-blind, placebo-controlled study. Drugs R D 2003 4 (1 19.
7. Neville BW, Damm DD, Allen CM, Bouquot JE, editors. Oral and Maxillofacial Pathology. 2nd ed., W. B. Saunders
8. Agbo-Godeau S. Aphthous stomatitis Rev Prat 2002 52 (4 380 384.
9. Durso SC. Oral manifestations of disease. In : Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J : Harrison's Principles of Internal Medicine. 17th ed.
10. Miles DA, Bricker SL, Razmus TF, Potter RH. Triamcinolone acetonide versus chlorhexidine for recurrent stomatitis. Oral Surg Oral Med Oral Pathol 1993 75 (3 397 462.
11. Hayrinen IR, Sorsa T, Konttinen YT, Teronen O, Malmstrom M. Effect of tetracylines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Pathol Med 1994 23 (6 269 272.
12. Naseri M, Mard S. Gastroprotective effect of alhagi maurorum on exprimental gastric ulcer in rats. Pak J Med Sci 2007 23 (4 570 573.
13. Singh VP, Yadav B, Pandey VB. Flavanone glycosides from Alhagi pseudalhagi. Phytochemistry 1999 51 (4 587 590.
14. Parmar NS. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor. Int J Tissue React 1983 5 (4 415 420.
15. Saxen MA, Ambrosius WT, Rehemtula al KF, Russell AL, Eckert GJ. Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 84 (4 356 361.
16. Ylikontiola L, Sorsa T, Hayrinen-Immonen R, Salo T. Doxymycine- cyanoacrylate treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 83 (3 329 333.
17. Sahba S, Mohammadalipour Sh. Recurrent Aphthous Stomatitis. Journal of Dentistry, Tehran University of Medical Sciences 2005 2 (4 147 151.
18. MacPhail L. Topical and systemic therapy for recurrent aphthous stomatitis. Semin Cutan Med Surg 1997 16 (4 301 307.
19. Ohashi M, Iwase M, Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J Oral Pathol Med 1999 28 (8 355 359.
20. Coskun S, Gulec EG, Balabanli B, Acarturk F. Effects of epidermal growth factor on lipid peroxidation and nitric oxide levels in oral mucosal ulcer healing: a time-course study. Surg Today 2007 37 (7 570 574.
21. Natah SS, Hayrinen-Immonen R, Hietanen J, Malmstrom M, Konttinen YT. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU). J Oral Pathol Med 2000 29 (1 19 25.
22. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Antiinflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007 2007 : 45673.
23. Torrado E, Adusumilli S, Fraga AG, Small PL, Castro AG, Pedrosa J. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun 2007 75 (8 3979 3988.